Table 3.
MINT 1 | MINT 2 | MINT 12 | MINT 31 | p16 | hMLH1-A | hMLH1-C | |
---|---|---|---|---|---|---|---|
HP | 4 (20%) | 9 (45%) | 7 (35%) | 5 (25%) | 6 (30%) | 10 (50%) | 2 (10%) |
Small adenoma | 2 (9.5%) | 10 (48%) | 2 (9.5%) | 2 (9.4%) | 3 (14%) | 3 (16%) | 1 (5.3%) |
Large adenoma | 4 (12.5%) | 7 (22%) | 12 (38%) | 1 (3%) | 4 (12.5%) | ND | ND |
CRC | 7 (29.2%) | 11 (46%) | 9 (37.5%) | 3 (12.5%) | 6 (25%) | 5 (21%) | 2 (8.3%) |
HP, hyperplastic polyp; CRC, colorectal carcinoma; ND, not done.